HL-1186

· Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HL-1186, covering 2025-08-24 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of HL-1186 in Patients With Diabetic Peripheral Neuropathic Pain [Phase 2]